Scientific Sessions 2025  /  TCT at AHA: Renal Denervation for Hypertension: What Comes Next?  /  Debate Pro: Predictors of Efficacy are Not Needed for Most Patients
Logo

American Heart Association

  34
  0

Final ID:

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

  • Sharp, Andrew  ( International Centre for Circulatory Health , London , United Kingdom )
    • Author Disclosures:
    Andrew Sharp: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Consultant:Boston Scientific:Active (exists now) ; Individual Stocks/Stock Options:Althea Medical:Active (exists now) ; Consultant:Penumbra:Active (exists now) ; Consultant:Angiodynamics:Active (exists now) ; Consultant:Philips:Active (exists now) ; Consultant:Recor Medical:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

TCT at AHA: Renal Denervation for Hypertension: What Comes Next?

Monday, 11/10/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
What Evaluation is Required for Patient Selection for RDN?

Fisher Naomi

Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

Bhatt Deepak

More abstracts from these authors:
Predictors of Home Blood Pressure Response to Ultrasound Renal Denervation

Sharp Andrew, Azizi Michel, Kirtane Ajay, Bloch Michael, Baker Lemont, Mcclure Candace K, Fisher Naomi

You have to be authorized to contact abstract author. Please, Login
Not Available